View all published articles.
MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C
Non-small lung cancer (NSCLC), with a poor 5-year survival rate (16%), is the major type of lung cancer. Metastasis has been identified as the main factor that leads to NSCLC therapy failure. MiR-206 is a meta...